TACE of Metastatic HCC to the Pleura

Slides:



Advertisements
Similar presentations
Intermediate stage HCC management
Advertisements

Staging Strategy and Treatment for Patients With HCC
These are actual cases to –Stimulate your reading –Test your knowledge of the material Look for the sound icon (often in the upper right hand corner.
High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Interventional Oncology Michael Kotton MD October 27, 2012.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Journal Meeting 時間 : AM 07:30 日期 : 06/29/2007 地點 : 胸腔外科辦公室 報告人 : R2 許博順.
Lung Masses.
Ayman Abdo MD, AmBIM, FRCPC
Hepatocellular Carcinoma Detection and Treatment
Liver Cancer Management with Y90 Glass Microspheres – TheraSphere Experience and Challenges in HCC Thomas Lauenstein, MD Department of Diagnostic and.
HCC Guidelines and recommendation Typical feature (wash in/wash out) New mass/nodule NoYes Alternative imaging technique Atypical featureTypical.
HEPATOCELLULAR CARCINOMA Monton. HCC in Thailand Most common cancer in Thai male Incidence 5 x 100,000 / year Male : female = 3-8:1 Age > 40 yr.
Guzman, Alexander Joseph Hipolito, April Lorraine
4 YEARS SURVIVAL OF 100 HCC PATIENTS TREATED WITH DC BEAD: A RETROSPECTIVE ANALYSIS Marta Burrel Vascular Interventional Unit Barcelona Clinic Liver Cancer.
Case Report # 1 Submitted by:James Korf, MS4 Faculty reviewer:Sandra Oldham, MD Date accepted:27 August 2014 Radiological Category:Principal Modality (1):
Dr Richard J Owen – Interventional Radiology
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
HCC Guidelines
HCC Guidelines and recommendation Diagnostic algorithm and recall policy.*One imaging technique only recommended in centers of excellence with high-end.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
Eun Sun Jang, M.D., Ph.D Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine Diseases.
 Macroscopic anatomy › External view › The quadrate lobe belongs anatomically to the right lobe and functionally to the left
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Management of Hepatocellular carcinoma
Treatment of Colorectal Cancer Metastases to the Liver David U. Kim, MD University of Wisconsin School of Medicine and Public Health Department of Radiology.
Combined Embolization/Ablation of RCC in a Solitary Kidney
Differential Diagnosis
Hepatocelluar carcinoma
Hepatocellular Carcinoma: Diagnosis and Management
Treatment of Oligometatic PNET Mets to Liver Following Resection
Portal Vein Stenting for Metastatic Neuroendocrine Tumor
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Case of the Month 19 January 2017
Benjamin R. Hart, Mazen El Atrache, Ashish Zalawadia
SD Walter MD1, T Mahten MD2, JW Harbour MD1,3
TRIBHUVAN UNIVERSITY TEACHING HOSPITAL
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Advantages of spiral CT
Standard Report Terms for Chest Computed Tomography Reports of Anterior Mediastinal Masses Suspicious for Thymoma  Edith M. Marom, MD, Melissa L. Rosado-de-Christenson,
Dig a Little Deeper: Adrenal
LIVER MRI Kyung Hee University Hospital Hyoung Jung Kim
2epart EXTRAPULMONARY SMALL CELL CANCER OF THE ESOPHAGUS INTRODUCTION
Hemangioendothelioma
Successful TACE for HCC
Locally-Advanced HCC:
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Chapter 14 Hepatic Tumors, Malignant 1
Cholangiocarcinoma in HBV Non-Cirrhotic
The 44th Congress of the Korean Association of HBP Surgery
AFP > 9000 without demonstrable HCC
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Annalisa K. Becker, MD, FRCPC, David K. Tso, MD, Alison C
Clinical Impact of Multidetector Row Computed Tomography Before Bronchial Artery Embolization in Patients With Hemoptysis: A Prospective Study  Mudit.
Multimodality Imaging of Tumour Thrombus
Functional imaging in liver tumours
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 
Example of pretreatment (A and B) and 8-week posttreatment (C and D) PET CT images. Example of pretreatment (A and B) and 8-week posttreatment (C and D)
Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C
The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma  Andy K.W. Chan, MD, FRCPC, Chris Hegarty, MB,
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3  Zhen Kang, Nan Wang, Anhui Xu, Liang.
Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular.
Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma 
Pleural Effusion and Renal Cell Carcinoma
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver resection or transplantation Prognostic effect of complete.
Multidisciplinary team approach to hepatocellular carcinoma management in a liver transplant center from Romania Cerban R.1, Iacob S.1, Croitoru A.1, Popescu.
Presentation transcript:

TACE of Metastatic HCC to the Pleura Gabriel Howles, MD, PhD Nishita Kothary MD Department of Radiology Division of Interventional Radiology Stanford University School of Medicine

Disclosures Gabriel Howles, MD, PhD None Nishita Kothary, MD Scientific Advisor, Siemens Healthcare Penn IR

History in Brief 68 Y Male hepatitis B and C negative Prior partial hepatectomy for a 4cm HCC (path: well differentiated HCC, no vascular invasion). On Sorafenib (400mg BID) Triphasic CT showed numerous hypervascular nodules with washout with the dominant burden in Couinaud segment VI, VII Pleural metastasis with chronic right pleural effusion seen on CT. Acc 8479365

Arterial phase of a triphasic CT, demonstrating multiple hypervascular foci in segment VI and VII that washed out on the portal venous and delayed phase (not shown), consistent with HCC

A B Axial and coronal images of the chest (A and B), demonstrate a 2.5cm x 2.5cm x 5cm pleural based, hypervascular nodule on the right, consistent with pleural metastatic disease

Laboratory Data AFP –Pre hepatectomy: 57, post-hepatectomy 28. At presentation:1137 LFT: Total Bilirubin 0.8mg/dL, AST 37 U/L, ALT 38 U/L, Albumin 3.7g/dL, INR 1.2 Creatinine 1.3mg/dL, Platelet count 78,000/µL

A B Early and delayed DSA imaging (A and B) of the thoracic aorta demonstrates arterial supply of pleural mets supplied by the intercostal arteries

A B Catheterization of the right 6th intercostal artery (A) and further selection and placement of a 1.9Fr microcatheter in the distal portion of the 6th intercostal artery (B), redemonstrates the hypervascular pleural met.

Pleural met treated with 31. 3mg of Doxrubicin and 0 Pleural met treated with 31.3mg of Doxrubicin and 0.625mL of Lipiodol (A). Prophylactic topical Ice was placed to prevent cutaneous complications of non-target chemoembolization. Unenhanced CBCT (B) demonstrates lipiodol staining in pleural met

A B Supply to pleural mets by 5th intercostal artery, treated in a similar superselective fashion.

MIP images reconstructed from a contrast enhanced CBCT obtained for radioembolization planning demonstrates multifocal HCC.

Clinical Course Patient returned for Y90 administration on Day 10. Erythema noted along the right posterior chest without ulceration. Asymptomatic, no treatment for chest wall. Uneventful administration of Y90. Skin erythema resolved, without consequences.

Discussion Lung is the most commonly affected organ of extrahepatic metastases from HCC 1 year survival is approximately 30% after diagnosis of pulmonary mets1 Prognostic factors that predict survival after diagnosis of pulmonary mets include oligometastasis, absence of pleural effusion and treatment of pulmonary metastases1

Discussion For intra- or extra-hepatic tumors supplied by extra-hepatic arteries (intercostal arteries or internal mammary arteries), cutaneous complications can occur when therapeutic agents are delivered due to the inadvertent deposition in the terminal cutaneous branches. Topical ice can be used to vasoconstrict cutaneous vasculature and prevent non-target deposition2.

Questions The commonest organ for extrahepatic metastatic disease from HCC is the: Brain Bone Lungs Mediastinal lymph nodes

Questions The commonest organ for extrahepatic metastatic disease from HCC is the: Brain Bone Lungs Mediastinal lymph nodes Answer B

Questions In patients with HCC metastatic to the lung, predictors of improved survival include Oligometastasis Absence of pleural effusion Treatment targeted to the pulmonary mets Resection of primary tumor All of the above

Questions In patients with HCC metastatic to the lung, predictors of improved survival include Oligometastasis Absence of pleural effusion Treatment targeted to the pulmonary mets Resection of primary tumor All of the above Answer E

References 1.Zhang SM et al: Prognostic analysis of pulmonary metastases from hepatocellular carcinoma: Hepatol Int 2008 Jun; 2(2): 237-243. 2. Wang DS et al: Prophylactic Topically Applied Ice to Prevent Cutaneous Complications of Nontarget Chemoembolization and Radioembolization. JVIR 2013 Apr, 24(4): 596-600